|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/18/2024 |
$41.88 |
$42.21 |
$41.70 |
$42.14 |
1.28M | 04/19/2024 |
$42.01 |
$42.23 |
$42.00 |
$42.21 |
813.30K | 04/22/2024 |
$42.28 |
$42.30 |
$41.86 |
$42.10 |
701.50K | 04/23/2024 |
$42.10 |
$42.14 |
$41.90 |
$41.99 |
1.39M | 04/24/2024 |
$41.97 |
$42.06 |
$41.87 |
$41.90 |
629.60K |
|
Cerevel Therapeutics Holdings is a clinical-stage biopharmaceutical company. Co.'s programs: Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype; Darigabat, which is a PAM that selectively targets the alpha-2/3/5 subunits of the GABAA receptor; Tavapadon, which is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of early- and late-stage Parkinson's disease; and CVL-871, which is a selective dopamine D1/D5 receptor partial agonist specifically designed to achieve a level of partial agonism. | |
|
Cerevel Therapeutics Holdings (CERE) has the following price history information. Looking back at CERE historical stock prices for the last five trading days, on April 18, 2024, CERE opened at $41.88, traded as high as $42.21 and as low as $41.70, and closed at $42.14. Trading volume was a total of 1.28M shares. On April 19, 2024, CERE opened at $42.01, traded as high as $42.23 and as low as $42.00, and closed at $42.21. Trading volume was a total of 813.30K shares. On April 22, 2024, CERE opened at $42.28, traded as high as $42.30 and as low as $41.86, and closed at $42.10. Trading volume was a total of 701.50K shares. On April 23, 2024, CERE opened at $42.10, traded as high as $42.14 and as low as $41.90, and closed at $41.99. Trading volume was a total of 1.39M shares. On April 24, 2024, CERE opened at $41.97, traded as high as $42.06 and as low as $41.87, and closed at $41.90. Trading volume was a total of 629.60K shares.
CERE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cerevel Therapeutics Holdings shares, starting with a $10,000 purchase of CERE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/31/2020 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$11.20 |
|
End price/share: |
$41.90 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
274.11% |
|
Average Annual Total Return: |
42.38% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$37,412.47 |
|
Years: |
3.73 |
|
|
|
Date |
Close |
04/18/2024 | $42.14 | 04/19/2024 | $42.21 | 04/22/2024 | $42.10 | 04/23/2024 | $41.99 | 04/24/2024 | $41.90 |
|
|